<HashMap><database>biostudies-literature</database><scores/><additional><submitter>Hernandez-Rodriguez X</submitter><funding>SECIHTI</funding><funding>Fundación IMSS A.C.</funding><pagination>2809</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC12736355</full_dataset_link><repository>biostudies-literature</repository><omics_type>Unknown</omics_type><volume>13(12)</volume><pubmed_abstract>SARS-CoV-2 continues to evolve into immune-evasive variants, and although vaccination remains the cornerstone of prevention, the search for antiviral molecules targeting conserved viral enzymes remains essential. The RNA-dependent RNA polymerase (NSP12) is a central component of coronavirus replication, and natural polyphenols have been recurrently proposed as modulators of viral polymerases. Among these compounds, Fisetin has been reported to interact with multiple viral and cellular pathways, yet its direct antiviral activity against SARS-CoV-2 remained largely unexplored. Here, we first analyzed the interaction of Fisetin with the catalytic and NiRAN domains of NSP12 using molecular docking and molecular dynamics simulations, revealing stable and energetically favorable binding througho</pubmed_abstract><journal>Microorganisms</journal><pubmed_title>Fisetin as an Antiviral Agent Targeting the RNA-Dependent RNA Polymerase of SARS-CoV-2: Computational Prediction and In Vitro Experimental Validation.</pubmed_title><pmcid>PMC12736355</pmcid><funding_grant_id>R-2024-785-073</funding_grant_id><funding_grant_id>CBF-2025-I-1331</funding_grant_id><pubmed_authors>De Jesus-Gonzalez LA</pubmed_authors><pubmed_authors>Castaneda-Delgado JE</pubmed_authors><pubmed_authors>Osuna-Ramos JF</pubmed_authors><pubmed_authors>Garcia-Herrera AC</pubmed_authors><pubmed_authors>Rivas-Santiago B</pubmed_authors><pubmed_authors>Santos-Mena AO</pubmed_authors><pubmed_authors>Reyes-Ruiz JM</pubmed_authors><pubmed_authors>Montano S</pubmed_authors><pubmed_authors>Lira-Hernandez FI</pubmed_authors><pubmed_authors>Calderon-Sandate DN</pubmed_authors><pubmed_authors>Angel RMD</pubmed_authors><pubmed_authors>Noriega S</pubmed_authors><pubmed_authors>Hernandez-Rodriguez X</pubmed_authors><pubmed_authors>Leon-Juarez M</pubmed_authors><pubmed_authors>Canedo-Figueroa DM</pubmed_authors><pubmed_authors>Farfan-Morales CN</pubmed_authors></additional><is_claimable>false</is_claimable><name>Fisetin as an Antiviral Agent Targeting the RNA-Dependent RNA Polymerase of SARS-CoV-2: Computational Prediction and In Vitro Experimental Validation.</name><description>SARS-CoV-2 continues to evolve into immune-evasive variants, and although vaccination remains the cornerstone of prevention, the search for antiviral molecules targeting conserved viral enzymes remains essential. The RNA-dependent RNA polymerase (NSP12) is a central component of coronavirus replication, and natural polyphenols have been recurrently proposed as modulators of viral polymerases. Among these compounds, Fisetin has been reported to interact with multiple viral and cellular pathways, yet its direct antiviral activity against SARS-CoV-2 remained largely unexplored. Here, we first analyzed the interaction of Fisetin with the catalytic and NiRAN domains of NSP12 using molecular docking and molecular dynamics simulations, revealing stable and energetically favorable binding througho</description><dates><release>2025-01-01T00:00:00Z</release><publication>2025 Dec</publication><modification>2026-05-28T03:20:45.994Z</modification><creation>2026-05-28T03:11:42.312Z</creation></dates><accession>S-EPMC12736355</accession><cross_references><pubmed>41472013</pubmed><doi>10.3390/microorganisms13122809</doi></cross_references></HashMap>